Jenne Kyle
- SEC CIK
- 0001791857
In the past year, 3 open-market sale filings worth $3.33M and no purchases.
Current role at each company
- IONS Ionis Pharmaceuticals IncEVP, Chf GL Pdt Str Ofcras of Apr 17, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.33M
- 3 filings
- Net
- −$3.33M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Jenne Kyle as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 17, 2026 (view filing) | Apr 16 | 1 day | Jenne KyleEVP, Chf GL Pdt Str Ofcr | SSale | −4.90K | $75.17 | −$368.5K | −17.1%23.7K after | |
| Mar 11, 2026 (view filing) | Mar 10 | 1 day | Jenne KyleEVP, Chf GL Pdt Str Ofcr | SSale | −37.3K | $75.85 | −$2.83M | −76.1%11.7K after | 2 lots10b5-1 |
| Jan 20, 2026 (view filing) | Jan 16 | 4 days | Jenne KyleEVP, Chf GL Pdt Str Ofcr | SSale | −1.82K | $75.96 | −$138.5K | −10.0%16.4K after | |
| Apr 17, 2025 (view filing) | Apr 16 | 1 day | Jenne KyleEVP, Chf GL Pdt Str Ofcr | SSale | −3.02K | $28.36 | −$85.5K | −21.2%11.2K after |